MeSH term
Frequency | Condition_Probility | Animals | 29 | 0.0 |
Humans | 36 | 0.0 |
Microtubules/*metabolism/ultrastructure | 2 | 25.0 |
Protein Binding | 11 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Comparative Study | 8 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Mice | 9 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Rats | 7 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
Female | 5 | 0.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Microtubule-Associated Proteins/metabolism | 5 | 3.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Paclitaxel/*pharmacology | 3 | 4.0 |
Phosphorylation | 9 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Vinblastine/pharmacology | 2 | 5.0 |
Antineoplastic Agents, Phytogenic/*pharmacology | 3 | 1.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
CDC2 Protein Kinase/metabolism | 3 | 1.0 |
Cell Line | 7 | 0.0 |
Microtubules/drug effects/*metabolism | 2 | 11.0 |
Nocodazole/pharmacology | 3 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Microtubules/*metabolism | 5 | 6.0 |
Models, Molecular | 3 | 0.0 |
Protein Conformation | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Binding Sites | 5 | 0.0 |
Cattle | 5 | 0.0 |
Kinetics | 2 | 0.0 |
Microtubules/metabolism | 4 | 3.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Tubulin/metabolism | 3 | 3.0 |
Microtubule-Associated Proteins/genetics/*metabolism | 4 | 10.0 |
Mutagenesis | 2 | 0.0 |
Swine | 3 | 0.0 |
Tubulin/*metabolism | 3 | 9.0 |
Hela Cells | 9 | 0.0 |
Microtubule-Associated Proteins/*metabolism | 2 | 1.0 |
Microtubules/*physiology | 3 | 18.0 |
Blotting, Western | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Phosphoserine/metabolism | 2 | 2.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Actins/metabolism | 2 | 0.0 |
CHO Cells | 6 | 0.0 |
Hamsters | 7 | 0.0 |
tau Proteins/metabolism | 3 | 4.0 |
*Microtubule Proteins | 2 | 6.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Protein p53/genetics/*metabolism | 2 | 1.0 |
Biopolymers | 2 | 1.0 |
*Drug Resistance, Neoplasm | 2 | 1.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Paclitaxel/pharmacology | 3 | 3.0 |
Microtubule-Associated Proteins/*physiology | 3 | 13.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Peptide Fragments/chemistry | 3 | 1.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Protozoan Proteins/*immunology | 2 | 15.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Transfection | 6 | 0.0 |
Base Sequence | 4 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Chickens | 2 | 0.0 |
Male | 4 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Microtubules/chemistry/*metabolism | 2 | 28.0 |
Microtubule-Associated Proteins/*chemistry | 2 | 16.0 |
Molecular Weight | 3 | 0.0 |
Excitatory Amino Acid Antagonists/*pharmacology | 2 | 22.0 |
Cercopithecus aethiops | 2 | 0.0 |
Mitotic Spindle Apparatus/*metabolism | 2 | 8.0 |
DNA Primers/chemistry | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Child | 2 | 0.0 |
Prevalence | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
